90632-20-5

Basic information

• Product Name: Ethanone, 1-[6-hydroxy-2,4-bis(methoxymethoxy)-3-(3-methyl-2-butenyl)phenyl]-
• Synonyms: 1-[6-Hydroxy-2,4-bis-methoxymethoxy-3-(3-methyl-but-2-enyl)-phenyl]-ethanone;1-(6-hydroxy-2,4-bis(methoxymethoxy)-3-(3-methylbut-2-enyl)phenyl)ethanone;6-hydroxy-2,4-dimethoxymethyl-3-prenylacetophenone;1-[6-hydroxy-2,4-dimethoxymethyloxy-3-(3-methyl-but-2-enyl)-phenyl]-ethanone;2-hydroxy-4,6-di(methoxymethoxy)-5-C-prenylacetophenone;2',4'-dimethoxymethyloxy-6'-hydroxy-3'-(3-methylbut-2-en-1-yloxy)acetophenone;2-hydroxy-5-(3,3-dimethyl)allyl-4,6-di(methoxymethoxy)acetophenone
• CAS NO: 90632-20-5
• Molecular Formula: C17H24O6
• Molecular Weight: 324.374
• Mol File: 90632-20-5.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 472.9±45.0 °C(Predicted)
• Density: 1.122±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Ethanone, 1-[6-hydroxy-2,4-bis(methoxymethoxy)-3-(3-methyl-2-butenyl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-[6-hydroxy-2,4-bis(methoxymethoxy)-3-(3-methyl-2-butenyl)phenyl]-(90632-20-5)
• EPA Substance Registry System: Ethanone, 1-[6-hydroxy-2,4-bis(methoxymethoxy)-3-(3-methyl-2-butenyl)phenyl]-(90632-20-5)

Safety Data

• Hazardous Substances Data: 90632-20-5(Hazardous Substances Data)

Upstream product

• 71386-98-6 2',4'-dihydroxy-6'-(methoxymethoxy)acetophenone 
• 108-73-6 3,5-dihydroxyphenol 
• 480-66-0 2,4,6-trihydroxyacetophenone 
• 65490-09-7 2'-hydroxy-4',6'-bis(methoxymethoxy)acetophenone 
• 870-63-3 prenyl bromide 
• 160624-22-6 1-{2,4-bis(methoxymethoxy)-6-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethanone 

Downstream Products

• 1400466-82-1 (2Z)-4,6-bis(methoxymethoxy)-2-[4-(methoxymethoxy)benzylidene]-5-(3-methylbut-2-en-1-yl)-1-benzofuran-3(2H)-one 
• 569-83-5 xanthohumol 
• 96169-02-7 Tetrahydroxanthohumol 
• 1034276-38-4 C₂₇H₃₄O₈ 
• 1228673-65-1 (2E)-1-(2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propen-1-one 
• 1034276-31-7 (2E)-1-(2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl)-3-(3,4-dimethoxyphenyl)-2-propen-1-one 

Relevant articles and documents

Total Synthesis of the Neuroprotective Agent Cudraisoflavone J

Cudraisoflavone J (1), isolated fromCudrania tricuspidata, is a potent neuroprotective compound with a chiral center. Herein, we report the first total synthesis of racemic cudraisoflavone J (1) using a Claisen rearrangement and a Suzuki coupling reaction as the key steps. Racemic secondary alcohol was kinetically resolved to give (+)- and (?)-cudraisoflavone J with up to 97 and 88% enantiomeric excess, respectively. The modified Mosher’s method was used to elucidate the absolute configuration of naturally occurring cudraisoflavone J.

Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues

Angiogenesis induction is a hallmark of cancer. Antiangiogenic properties of Xanthohumol (XN), a naturally occurring prenylated chalcone from hops, have been widely reported. Here we describe the synthesis and study the antiangiogenic activity in vitro of

Xanthohumol, a polyphenol chalcone present in hops, activating nrf2 enzymes to confer protection against oxidative damage in pc12 cells

Xanthohumol (2a?2,4a?2,4-trihydroxy-6a?2-methoxy-3a?2-prenylchalcone, Xn), a polyphenol chalcone from hops (Humulus lupulus), has received increasing attention due to its multiple pharmacological activities. As an active component in beers, its presence has been suggested to be linked to the epidemiological observation of the beneficial effect of regular beer drinking. In this work, we synthesized Xn with a total yield of 5.0% in seven steps and studied its neuroprotective function against oxidative-stress-induced neuronal cell damage in the neuronlike rat pheochromocytoma cell line PC12. Xn displays moderate free-radical-scavenging capacity in vitro. More importantly, pretreatment of PC12 cells with Xn at submicromolar concentrations significantly upregulates a panel of phase II cytoprotective genes as well as the corresponding gene products, such as glutathione, heme oxygenase, NAD(P)H:quinone oxidoreductase, thioredoxin, and thioredoxin reductase. A mechanistic study indicates that the ?±,?2-unsaturated ketone structure in Xn and activation of the transcription factor Nrf2 are key determinants for the cytoprotection of Xn. Targeting the Nrf2 by Xn discloses a previously unrecognized mechanism underlying the biological action of Xn. Our results demonstrate that Xn is a novel small-molecule activator of Nrf2 in neuronal cells and suggest that Xn might be a potential candidate for the prevention of neurodegenerative disorders.